Faculty of Continuing Education, Riga Stradins University, Riga, Latvia,
Department of Internal Medicine, Riga Stradins University, Riga, Latvia,
Med Princ Pract. 2019;28(3):264-272. doi: 10.1159/000497436. Epub 2019 Feb 4.
In-hospital mortality for patients presenting with acute pulmonary embolism (PE) has been reported to be up to 7 times higher for patients with decreased estimated glomerular filtration rate (eGFR). However, few studies have assessed its effect on long-term mortality.
To determine the impact of eGFR and creatinine clearance (CrCl) on long-term all-cause mortality following acute PE in association with other routine laboratory analyses and comorbidities.
PATIENTS/METHODS: The prospective study enrolled 141 consecutive patients presenting with objectively confirmed acute PE. Demographic, clinical data, comorbidities, and laboratory values were recorded. CrCl and GFR were estimated using the Cockcroft-Gault, MDRD, and chronic kidney disease (CKD)-EPI equations. Patients were followed up at 90 days and 1 year after the event.
In univariate analyses, age, active cancer, PE severity index (PESI), CrCl and eGFR, D-dimer value, and high-density lipoprotein level were found to be significantly associated with mortality in 90 days and 1 year. Additionally, body mass index was significant in the 1-year follow-up. CrCl by Cockcroft-Gault (90-day: area under the curve [AUC] 0.763; 1-year: AUC 0.718) demonstrated higher discriminatory power for predicting mortality than eGFR by the MDRD (AUC 0.686; AUC 0.609) and CKD-EPI (AUC 0.697; AUC 0.630) equations. In multivariate analyses, active cancer, CrCl by Cockcroft-Gault (90-day: hazard ratio [HR] 0.948, 95% CI 0.919-0.979; 1-year: HR 0.967, 95% CI 0.943-0.991), eGFR by CKD-EPI (90-day: HR 0.948, 95% CI 0.915-0.983; 1-year: HR 0.971, 95% CI 0.945-0.998) were found to be independent predictors of mortality. eGFR by MDRD, D-dimer, and PESI value were significant prognostic factors for 90-day mortality.
Decreased renal function is a prognostic factor for increased all-cause mortality 90 days and 1 year after acute PE.
患有急性肺栓塞(PE)的患者肾小球滤过率(eGFR)降低,其院内死亡率高达 7 倍。然而,很少有研究评估其对长期死亡率的影响。
确定 eGFR 和肌酐清除率(CrCl)对急性 PE 后长期全因死亡率的影响,并结合其他常规实验室分析和合并症进行评估。
患者/方法:这项前瞻性研究纳入了 141 例经客观证实的急性 PE 连续患者。记录人口统计学、临床数据、合并症和实验室值。使用 Cockcroft-Gault、MDRD 和慢性肾脏病(CKD)-EPI 方程估计 CrCl 和 GFR。患者在事件发生后 90 天和 1 年进行随访。
在单因素分析中,年龄、活动性癌症、PE 严重指数(PESI)、CrCl 和 eGFR、D-二聚体值和高密度脂蛋白水平与 90 天和 1 年的死亡率显著相关。此外,体重指数在 1 年随访中具有显著性。Cockcroft-Gault 法计算的 CrCl(90 天:曲线下面积 [AUC] 0.763;1 年:AUC 0.718)在预测死亡率方面的判别能力高于 MDRD(AUC 0.686;AUC 0.609)和 CKD-EPI(AUC 0.697;AUC 0.630)方程计算的 eGFR。多因素分析显示,活动性癌症、Cockcroft-Gault 法计算的 CrCl(90 天:风险比 [HR] 0.948,95%CI 0.919-0.979;1 年:HR 0.967,95%CI 0.943-0.991)和 CKD-EPI 方程计算的 eGFR(90 天:HR 0.948,95%CI 0.915-0.983;1 年:HR 0.971,95%CI 0.945-0.998)是死亡率的独立预测因素。MDRD 计算的 eGFR、D-二聚体和 PESI 值是 90 天死亡率的重要预后因素。
急性 PE 后 90 天和 1 年,肾功能下降是全因死亡率增加的一个预后因素。